KPNA4 and prostate carcinoma: The expression of KPNA4 in prostate cancer was shown to promote metastasis through miR-708-KPNA4-TNF axes (Yang et al., 2017), and KPNA4 was found to enhance cancer cell proliferation and cisplatin resistance in cutaneous squamous cell carcinoma (Zhang et al., 2019).